Bromsite is owned by Sun Pharm.
Bromsite contains Bromfenac Sodium.
Bromsite has a total of 1 drug patent out of which 0 drug patents have expired.
Bromsite was authorised for market use on 08 April, 2016.
Bromsite is available in solution/drops;ophthalmic dosage forms.
Bromsite can be used as treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery.
The generics of Bromsite are possible to be released after 07 August, 2029.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US8778999||SUN PHARM||Non-steroidal anti-inflammatory ophthalmic compositions|| |
(6 years from now)
Drugs and Companies using BROMFENAC SODIUM ingredient
Market Authorisation Date: 08 April, 2016
Treatment: Treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic